Article · Revue · 2007

Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up

Hussein A Sheashaa, Mohamed A. Bakr, Mohamed Ashraf Fouda, Khalid F. El-dahshan, A. M. Ismail, Mohammed Sobh et 1 autres

International Urology and Nephrology

• Accès fermé

Aller chez l’éditeur10.1007/s11255-006-9091-8